DE122009000067I1 - Use of bi- and trispecific antibodies to induce tumor immunity - Google Patents

Use of bi- and trispecific antibodies to induce tumor immunity

Info

Publication number
DE122009000067I1
DE122009000067I1 DE122009000067C DE122009000067C DE122009000067I1 DE 122009000067 I1 DE122009000067 I1 DE 122009000067I1 DE 122009000067 C DE122009000067 C DE 122009000067C DE 122009000067 C DE122009000067 C DE 122009000067C DE 122009000067 I1 DE122009000067 I1 DE 122009000067I1
Authority
DE
Germany
Prior art keywords
tumor immunity
induce tumor
trispecific antibodies
trispecific
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE122009000067C
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Publication of DE122009000067I1 publication Critical patent/DE122009000067I1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE122009000067C 1996-09-03 1997-09-02 Use of bi- and trispecific antibodies to induce tumor immunity Pending DE122009000067I1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19635743 1996-09-03
DE19648976 1996-11-26
DE19710497A DE19710497C2 (en) 1996-09-03 1997-03-13 Use bi- and trispecific antibodies to induce tumor immunity

Publications (1)

Publication Number Publication Date
DE122009000067I1 true DE122009000067I1 (en) 2010-01-21

Family

ID=26028995

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19710497A Expired - Fee Related DE19710497C2 (en) 1996-09-03 1997-03-13 Use bi- and trispecific antibodies to induce tumor immunity
DE59707355T Expired - Lifetime DE59707355D1 (en) 1996-09-03 1997-09-02 Use of bi-specific and trispecific antibodies to induce tumor immunity
DE122009000067C Pending DE122009000067I1 (en) 1996-09-03 1997-09-02 Use of bi- and trispecific antibodies to induce tumor immunity

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE19710497A Expired - Fee Related DE19710497C2 (en) 1996-09-03 1997-03-13 Use bi- and trispecific antibodies to induce tumor immunity
DE59707355T Expired - Lifetime DE59707355D1 (en) 1996-09-03 1997-09-02 Use of bi-specific and trispecific antibodies to induce tumor immunity

Country Status (2)

Country Link
DE (3) DE19710497C2 (en)
NL (1) NL300420I1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018435A1 (en) * 1998-09-25 2000-04-06 Horst Lindhofer Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
DE10043437A1 (en) 2000-09-04 2002-03-28 Horst Lindhofer Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
DE10261223A1 (en) * 2002-12-20 2004-07-08 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Increasing the immune response through substances that influence the function of natural killer cells
DE102006006879A1 (en) * 2006-02-15 2007-08-23 Sascha Struffi Flat armpit sweat absorber for placing under an armpit comprises adhesive surfaces arranged on its upper side
EP1820513A1 (en) 2006-02-15 2007-08-22 Trion Pharma Gmbh Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4419399C1 (en) * 1994-06-03 1995-03-09 Gsf Forschungszentrum Umwelt Process for the preparation of heterologous bispecific antibodies

Also Published As

Publication number Publication date
DE19710497C2 (en) 1998-07-09
NL300420I1 (en) 2010-01-04
DE59707355D1 (en) 2002-07-04
DE19710497A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DE69730892D1 (en) Processing of retraction points to create sheets using memory reduction techniques
DE4290881T1 (en) Procedure for massage of the spine area
DE69739418D1 (en) System for stimulation of stimulation
DE69130246T2 (en) System for the formation of sentences
DE69810957T2 (en) HIGHLY EFFICIENT ABSORBENT ARTICLE FOR USE WITH MONTHSHOSE
DE69713295D1 (en) AZABICYCLISHE CARBANIUMSAUREESTER FOR THERAPEUTIC USE
AT387718B (en) ARTIFICIAL FERTILIZATION CATHEDER
DE69813935D1 (en) Use of retinoids to induce skin pigmentation
DE69224670D1 (en) Process for the formation and maintenance of an artificial snow cover
DE69819006D1 (en) USE OF GINSENOSIDE RB1 FOR STIMULATING ELASTINE SYNTHESIS
DE69526935T2 (en) USE OF MYCOBACTERIUM FOR TUMOR TREATMENT
ATA62196A (en) USE OF POLYPROPYLENES TO IMPROVE STABILITY TO IONIZING RADIATION
ATE217518T1 (en) USE OF AT LEAST ONE 6-POSITION SUBSTITUTED PYRIMIDINE-3-OXIDE TO STIMULATE TYROSINASE
DE69702862T2 (en) USE OF SULFATED POLYSACCHARIDES TO TREAT CHRONIC INJURY
DE69704855T2 (en) INDUCTION HEATER FOR THE SURFACE TREATMENT OF GEARS
ATE218862T1 (en) USE OF 1-HYDROXY-2-PYRIDONES TO TREAT SKIN INFECTIONS
DE122009000067I1 (en) Use of bi- and trispecific antibodies to induce tumor immunity
ATE270102T1 (en) USE OF BENZOPYRANOLS TO TREAT NEUROLOGICAL DISEASES
DE69802734T2 (en) Use of stevia extracts to produce an antihistamine composition
DE59208571D1 (en) Process for the preparation of fluorine-substituted aminobenzodioxoles and benzodioxanes and new intermediates
DE59811806D1 (en) USE OF SELECTED PHYTOSTENOLESTERS FOR PRODUCING HYPOCHOLESTERINEMIC AGENTS
AT400232B (en) DEVICE FOR PRODUCING FLOATING SCREED
DE59107918D1 (en) Procedure to minimize the risk of accidents
DE69811441D1 (en) Treatment method to reduce surface energy
DE69725876D1 (en) ORNAMENTAL COMPOSITE MADE OF NATURAL STONE